{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:15:36Z","timestamp":1790129736891,"version":"4.0.1"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.pharmthera.2023.108434","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T11:54:09Z","timestamp":1683719649000},"page":"108434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy"],"prefix":"10.1016","volume":"247","author":[{"given":"Shu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaming","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108434_bb0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bioorg.2018.09.001","article-title":"Identification of new pyrrolo [2, 3-d] pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling","volume":"81","author":"Adel","year":"2018","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijbiomac.2022.03.057","article-title":"A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors","volume":"207","author":"Aghanejad","year":"2022","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.595526","article-title":"Role of NO and S-nitrosylation in the expression of endothelial adhesion proteins that regulate leukocyte and tumor cell adhesion","volume":"11","author":"Aguilar","year":"2020","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0020","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1878-0261.12504","article-title":"Fibroblast growth factor signals regulate transforming growth factor-\u03b2-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1","volume":"13","author":"Akatsu","year":"2019","journal-title":"Molecular Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0025","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/1078-0432.CCR-04-0516","article-title":"The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2\u2032-deoxycytidine","volume":"10","author":"Alleman","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13046-023-02628-x","article-title":"Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells","volume":"42","author":"Amaro","year":"2023","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0035","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Current Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13046-022-02529-5","article-title":"Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy","volume":"41","author":"Anichini","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0045","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1016\/j.biomaterials.2014.04.087","article-title":"An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells","volume":"35","author":"Ara","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101912","article-title":"Molecular insight of regorafenib treatment for colorectal cancer","volume":"81","author":"Arai","year":"2019","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/jm401419p","article-title":"Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1","volume":"57","author":"Asgatay","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4161\/cbt.27630","article-title":"MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines","volume":"15","author":"Azizi","year":"2014","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0490-2","article-title":"PKM2 promotes tumor angiogenesis by regulating HIF-1\u03b1 through NF-\u03baB activation","volume":"15","author":"Azoitei","year":"2016","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0070","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.3390\/ijms20092241","article-title":"Immunoepigenetics combination therapies: an overview of the role of HDACs in cancer immunotherapy","volume":"20","author":"Banik","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.111915","article-title":"NT5E DNA methylation in papillary thyroid cancer: Novel opportunities for precision oncology","volume":"570","author":"Bertoni","year":"2023","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166428","article-title":"PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma","volume":"1868","author":"Bhol","year":"2022","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0090","article-title":"Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer","volume":"nwad094","author":"Bian","year":"2023","journal-title":"National Science Review"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","article-title":"Epigenetics in cancer: Fundamentals and Beyond","volume":"173","author":"Biswas","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0100","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1147939","article-title":"UHRF1 plays a role in maintaining DNA methylation in mammalian cells","volume":"317","author":"Bostick","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0105","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1096\/fj.02-0557fje","article-title":"Altered angiogenesis and survival in human tumor-derived endothelial cells","volume":"17","author":"Bussolati","year":"2003","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0110","article-title":"Beyond nicotinamide metabolism: potential role of nicotinamide N-methyltransferase as a biomarker in skin cancers","volume":"13, 4943","author":"Campagna","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ccell.2016.11.010","article-title":"Molecular checkpoint decisions made by subverted vascular niche transform indolent tumor cells into chemoresistant cancer stem cells","volume":"31","author":"Cao","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/biom7010003","article-title":"DNA methylation targeting: the DNMT\/HMT crosstalk challenge","volume":"7","author":"Castillo-Aguilera","year":"2017","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0125","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMc1915189","article-title":"Reversal of TGF\u03b21-driven profibrotic state in patients with pulmonary fibrosis","volume":"382","author":"Chapman","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-016-0219-6","article-title":"Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer","volume":"23","author":"Cheng","year":"2016","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0135","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms21072606","article-title":"The epigenetic profile of tumor endothelial cells. Effects of combined therapy with antiangiogenic and epigenetic drugs on cancer progression","volume":"21","author":"Ciesielski","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"Croix","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0145","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1182\/blood-2021-153698","article-title":"Transcriptomic Signitures of Azacitidine (AZA) and Decitabine (DAC) Resistance in MDS and CMML","volume":"138","author":"Darbaniyan","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0150","doi-asserted-by":"crossref","unstructured":"Davalos, V., & Esteller, M. (2022). Cancer epigenetics in clinical practice. CA: a Cancer Journal for Clinicians. Online ahead of print.","DOI":"10.3322\/caac.21765"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0155","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S1470-2045(21)00242-4","article-title":"Elective nodal radiotherapy in prostate cancer","volume":"22","author":"De Meerleer","year":"2021","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biocel.2019.01.016","article-title":"Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells","volume":"109","author":"Deshmukh","year":"2019","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0170","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40265-020-01389-7","article-title":"Decitabine\/cedazuridine: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0175","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2021-150523","article-title":"The interim efficacy of epigenetic priming regimen with azacytidine and chidamide in patients with relapsed or refractory peripheral T cell lymphoma","volume":"138","author":"Ding","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0180","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.1522491113","article-title":"Human DNMT1 transition state structure","volume":"113","author":"Du","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0185","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41581-022-00662-0","article-title":"Gasdermins and pyroptosis in the kidney","volume":"19","author":"Elias","year":"2023","journal-title":"Nature Reviews Nephrology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0190","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1200\/JCO.2022.40.16_suppl.2072","article-title":"Prostate-specific membrane antigen expression in meningioma. In: American Society of Clinical Oncology","volume":"40","author":"Elinzano","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41467-022-35222-4","article-title":"Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation","volume":"14","author":"Esposito","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejca.2022.09.009","article-title":"Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy","volume":"176","author":"Evans","year":"2022","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0205","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance","volume":"66","author":"Fan","year":"2022","journal-title":"Drug Resistance Updates"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02382-6","article-title":"GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma","volume":"41","author":"Fang","year":"2022","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0215","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0220","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1158\/0008-5472.CAN-22-2236","article-title":"DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations","volume":"83","author":"Gallon","year":"2023","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0960","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fonc.2018.00248","article-title":"Unraveling the role of angiogenesis in cancer ecosystems","volume":"8","author":"Zuazo-Gaztelu","year":"2018","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0225","doi-asserted-by":"crossref","unstructured":"Gao, T., Sang, X., Huang, X., Gu, P., Liu, J., Liu, Y., & Zhang, N. (2022). Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer. Acta Pharmaceutica Sinica B. In Press","DOI":"10.1016\/j.apsb.2022.11.018"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0230","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1021\/acs.jmedchem.1c01094","article-title":"Potent inhibition of nicotinamide N-methyltransferase by alkene-linked bisubstrate mimics bearing electron deficient aromatics","volume":"64","author":"Gao","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood-2020-134979","article-title":"PIM kinase inhibition decreases the proangiogenic properties of multiple myeloma cells and affects the metabolic state of the vascular endothelium","volume":"136","author":"Garbicz","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0240","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1016\/S2352-3026(22)00403-3","article-title":"Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study","volume":"10","author":"Garcia-Manero","year":"2023","journal-title":"The Lancet Haematology"},{"issue":"142\u2013157","key":"10.1016\/j.pharmthera.2023.108434_bb0245","article-title":"De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0250","first-page":"2989","article-title":"DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer","volume":"33","author":"Gnyszka","year":"2013","journal-title":"Anticancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0255","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1120976","article-title":"Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2","volume":"311","author":"Goll","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0260","doi-asserted-by":"crossref","first-page":"115070","DOI":"10.1016\/j.ejmech.2022.115070","article-title":"Inhibitors of ABCG2-mediated multidrug resistance: Lead generation through computer-aided drug design","volume":"248","author":"Goracci","year":"2023","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0265","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2174\/13816128113199990516","article-title":"Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells","volume":"20","author":"Gra\u00e7a","year":"2014","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-021-03689-8","article-title":"BANP opens chromatin and activates CpG-island-regulated genes","volume":"596","author":"Grand","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00286709","article-title":"Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma","volume":"83","author":"Greger","year":"1989","journal-title":"Human Genetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-5876-4-13","article-title":"Tumor-associated endothelial cells display GSTP1 and RAR\u03b22 promoter methylation in human prostate cancer","volume":"4","author":"Grover","year":"2006","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0285","doi-asserted-by":"crossref","first-page":"12116","DOI":"10.1093\/nar\/gkaa1003","article-title":"A role for LSH in facilitating DNA methylation by DNMT1 through enhancing UHRF1 chromatin association","volume":"48","author":"Han","year":"2020","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0740","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.rbmo.2016.08.022","article-title":"DNA methyltransferases exhibit dynamic expression during spermatogenesis","volume":"33","author":"Uysal","year":"2016","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0290","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1039\/D1CB00134E","article-title":"Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT)","volume":"2","author":"van Haren","year":"2021","journal-title":"RSC Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0295","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.apsb.2021.11.002","article-title":"Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K\/AKT pathway","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0300","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-022-01597-7","article-title":"Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4\/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer","volume":"21","author":"Heidegger","year":"2022","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0305","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1158\/0008-5472.CAN-06-1609","article-title":"Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications","volume":"66","author":"Hellebrekers","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0310","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/0008-5472.CAN-06-3032","article-title":"Identification of epigenetically silenced genes in tumor endothelial cells","volume":"67","author":"Hellebrekers","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-380866-0.60001-0","article-title":"Introduction: epigenetics and cancer","volume":"70","author":"Herceg","year":"2010","journal-title":"Advances in Genetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0320","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jb\/mvs152","article-title":"Tumour endothelial cells acquire drug resistance in a tumour microenvironment","volume":"153","author":"Hida","year":"2013","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0325","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/ijms19051272","article-title":"Contribution of tumor endothelial cells in cancer progression","volume":"19","author":"Hida","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0330","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0335","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1756-8722-6-49","article-title":"Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy","volume":"6","author":"Huang","year":"2013","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0340","doi-asserted-by":"crossref","first-page":"13045","DOI":"10.1093\/nar\/gkab1148","article-title":"Position 34 of tRNA is a discriminative element for m5C38 modification by human DNMT2","volume":"49","author":"Huang","year":"2021","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0345","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.113.086801","article-title":"The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells","volume":"84","author":"Hummel-Eisenbeiss","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111683","article-title":"Self-assembled VEGF-R2 targeting DNA aptamer-collagen fibers stimulate an angiogenic-like endothelial cell phenotype","volume":"120","author":"James","year":"2021","journal-title":"Materials science & engineering. C, Materials for biological applications"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0355","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0360","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020618","article-title":"Efficacy and safety of ramucirumab treatment in patients with advanced colorectal cancer: A protocol for systematic review and meta analysis","volume":"99","author":"Ju","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0365","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15592294.2016.1214781","article-title":"Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma","volume":"11","author":"Jueliger","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0370","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1038\/s41467-022-34779-4","article-title":"Structural basis for activation of DNMT1","volume":"13","author":"Kikuchi","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0375","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1748-717X-7-39","article-title":"DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity","volume":"7","author":"Kim","year":"2012","journal-title":"Radiation Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0380","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/15384047.2015.1017154","article-title":"Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II \u03b1","volume":"16","author":"Kim","year":"2015","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0385","doi-asserted-by":"crossref","first-page":"e16197","DOI":"10.1200\/JCO.2021.39.15_suppl.e16197","article-title":"Methylation status of eight tumor suppressors in neuroendocrine pancreatic tumors. In: Ameirican Society of Clinical Oncology","volume":"39","author":"Kit","year":"2021","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0390","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","article-title":"Analysis of DNA methylation in cancer: location revisited","volume":"15","author":"Koch","year":"2018","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0395","first-page":"1129","article-title":"Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study","volume":"30","author":"Kourea","year":"2015","journal-title":"Histology and Histopathology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0400","first-page":"167","article-title":"Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells","volume":"55","author":"Kumanishi","year":"2019","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0405","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41586-022-04888-7","article-title":"GREM1 is required to maintain cellular heterogeneity in pancreatic cancer","volume":"607","author":"Lan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0410","doi-asserted-by":"crossref","first-page":"107800","DOI":"10.1016\/j.pharmthera.2021.107800","article-title":"Trailblazing perspectives on targeting breast cancer stem cells","volume":"223","author":"Li","year":"2021","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0415","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41416-023-02155-8","article-title":"A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer","volume":"128","author":"Li","year":"2023","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0420","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.aar5557","article-title":"Targeting angiogenic metabolism in disease","volume":"359","author":"Li","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0425","article-title":"Nicotinamide N-methyltransferase: a promising biomarker and target for human cancer therapy","volume":"12","author":"Li","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0430","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1007\/s13277-014-1634-5","article-title":"Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2\/M checkpoint response and apoptosis in osteosarcoma cells","volume":"35","author":"Li","year":"2014","journal-title":"Tumor Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0435","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/cancers14112735","article-title":"Cancer-induced metabolic rewiring of tumor endothelial cells","volume":"14","author":"Lidonnici","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0440","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1158\/1078-0432.CCR-22-2168","article-title":"A phase II trial of guadecitabine in children and adults with SDH-deficient GIST, pheochromocytoma, paraganglioma, and HLRCC-associated renal cell carcinoma","volume":"29","author":"Ligon","year":"2023","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0445","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/ATVBAHA.117.310506","article-title":"Inhibition of endothelial SCUBE2 (signal peptide-CUB-EGF domain-containing protein 2), a novel VEGFR2 (vascular endothelial growth factor receptor 2) coreceptor, suppresses tumor angiogenesis","volume":"38","author":"Lin","year":"2018","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.matbio.2012.11.010","article-title":"Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis","volume":"32","author":"Lindner","year":"2013","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0455","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12916-023-02842-6","article-title":"Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo-YAP1 pathway","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0460","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bioactmat.2021.10.011","article-title":"DNA aptamer S11e recognizes fibrosarcoma and acts as a tumor suppressor","volume":"12","author":"Liu","year":"2022","journal-title":"Bioactive Materials"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0465","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.18632\/oncotarget.1269","article-title":"Isolation and genome-wide expression and methylation characterization of CD31+ cells from normal and malignant human prostate tissue","volume":"4","author":"Luo","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gendis.2016.11.003","article-title":"The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism","volume":"4","author":"Lv","year":"2017","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0475","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1200\/JCO.2022.40.16_suppl.2030","article-title":"Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma","volume":"40","author":"Ly","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105071","article-title":"DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents","volume":"160","author":"Ma","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0485","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2014.01.001","article-title":"Exploiting epigenetic vulnerabilities for cancer therapeutics","volume":"35","author":"Mair","year":"2014","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0490","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/cancers11101511","article-title":"Tumor endothelial heterogeneity in cancer progression","volume":"11","author":"Maishi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0495","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","article-title":"DNA methylation: a historical perspective","volume":"38","author":"Mattei","year":"2022","journal-title":"Trends in Genetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0500","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/1878-0261.12536","article-title":"Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer","volume":"13","author":"Mazzu","year":"2019","journal-title":"Molecular Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0505","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s43018-021-00271-z","article-title":"The next generation of DNMT inhibitors","volume":"2","author":"Mehdipour","year":"2021","journal-title":"Nature Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0510","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-1979-4","article-title":"The guidance receptor plexin D1 is a mechanosensor in endothelial cells","volume":"578","author":"Mehta","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0515","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/ijo.2013.1960","article-title":"Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3","volume":"43","author":"Meng","year":"2013","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0520","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0030-1253448","article-title":"Heterogeneity in endothelial responsiveness to cytokines, molecular causes, and pharmacological consequences","volume":"36","author":"Molema","year":"2010","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0525","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13148-018-0602-0","article-title":"Epigenetic therapy for ovarian cancer: promise and progress","volume":"11","author":"Moufarrij","year":"2019","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0530","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.biopha.2017.03.093","article-title":"PLGA-PEG nano-delivery system for epigenetic therapy","volume":"90","author":"Naz","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0535","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends in Genetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0540","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1016\/j.apsb.2022.11.002","article-title":"Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics","volume":"12","author":"Niu","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0545","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-05043-y","article-title":"Cell-matrix interface regulates dormancy in human colon cancer stem cells","volume":"608","author":"Ohta","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0550","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0555","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317708547","article-title":"Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2\u2013mediated angiogenesis","volume":"39","author":"Pan","year":"2017","journal-title":"Tumor Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-017-0467-0","article-title":"DNA methylation profiles in cancer diagnosis and therapeutics","volume":"18","author":"Pan","year":"2018","journal-title":"Clinical and Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0565","doi-asserted-by":"crossref","first-page":"e004495","DOI":"10.1136\/jitc-2022-004495","article-title":"Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors","volume":"10","author":"Papadatos-Pastos","year":"2022","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0570","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","article-title":"DNA methylation profiling: an emerging paradigm for cancer diagnosis","volume":"17","author":"Papanicolau-Sengos","year":"2022","journal-title":"Annual Review of Pathology: Mechanisms"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0575","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","article-title":"Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia","volume":"2","author":"Pappalardi","year":"2021","journal-title":"Nature Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0580","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1158\/2159-8290.CD-21-1671","article-title":"PRC2-inactivating mutations in cancer enhance cytotoxic response to DNMT1-targeted therapy via enhanced viral mimicry","volume":"12","author":"Patel","year":"2022","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0585","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular Mechanisms and Future Implications of VEGF\/VEGFR in Cancer Therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0590","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.2022018246","article-title":"Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease","volume":"141","author":"Penter","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0595","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/nar\/gkaa1154","article-title":"Staying true to yourself: mechanisms of DNA methylation maintenance in mammals","volume":"49","author":"Petryk","year":"2021","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0600","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/cancers10080268","article-title":"The methylation status of the epigenome: its emerging role in the regulation of tumor angiogenesis and tumor growth, and potential for drug targeting","volume":"10","author":"Pirola","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1097-0045(20000615)44:1<77::AID-PROS10>3.0.CO;2-G","article-title":"Endothelium-derived factors as paracrine mediators of prostate cancer progression","volume":"44","author":"Pirtskhalaishvili","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0610","doi-asserted-by":"crossref","first-page":"155594","DOI":"10.1038\/ncomms15594","article-title":"Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions","volume":"8","author":"Qiu","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108434_bb9962","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2407-12-19","article-title":"DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)","volume":"12","author":"Quentmeier","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0615","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Ricci-Vitiani","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0620","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-019-0675-4","article-title":"Epigenetics in cancer therapy and nanomedicine","volume":"11","author":"Roberti","year":"2019","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0625","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4155\/fmc-2017-0074","article-title":"Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors","volume":"9","author":"Rondelet","year":"2017","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0630","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fimmu.2019.00147","article-title":"Support of tumor endothelial cells by chemokine receptors","volume":"10","author":"Salazar","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0635","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature14192","article-title":"Function and information content of DNA methylation","volume":"517","author":"Sch\u00fcbeler","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0640","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/dna.2019.4934","article-title":"Procaine and S-adenosyl-l-homocysteine affect the expression of genes related to the epigenetic machinery and change the DNA methylation status of in vitro cultured bovine skin fibroblasts","volume":"39","author":"Schumann","year":"2020","journal-title":"DNA and Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0645","first-page":"1596","article-title":"Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy","volume":"9","author":"Segura-Pacheco","year":"2003","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0650","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1158\/1078-0432.CCR-17-0235","article-title":"Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia","volume":"23","author":"Shen","year":"2017","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150319","article-title":"Therapeutic effects of procainamide on endotoxin-induced rhabdomyolysis in rats","volume":"11","author":"Shih","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0660","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/ajh.26667","article-title":"Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directions","volume":"97","author":"Short","year":"2022","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0665","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccell.2019.01.004","article-title":"DNA hypermethylation encroachment at CpG island borders in cancer is predisposed by H3K4 monomethylation patterns","volume":"35","author":"Skvortsova","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0670","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3390\/ijms19103106","article-title":"Polyamine metabolism and gene methylation in conjunction with one-carbon metabolism","volume":"19","author":"Soda","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0675","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1126\/science.1214453","article-title":"Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation","volume":"335","author":"Song","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0680","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/annonc\/mdg216","article-title":"A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly","volume":"14","author":"Stewart","year":"2003","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0685","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1868-7083-6-2","article-title":"Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors","volume":"6","author":"Stewart","year":"2014","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0690","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12760","article-title":"A novel melatonin-regulated lncRNA suppresses TPA-induced oral cancer cell motility through replenishing PRUNE2 expression","volume":"71","author":"Su","year":"2021","journal-title":"Journal of Pineal Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0695","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13046-018-0988-8","article-title":"Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors","volume":"37","author":"Su","year":"2018","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0700","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-017-0567-4","article-title":"Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2","volume":"36","author":"Sun","year":"2017","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0705","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12885-020-6674-1","article-title":"Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: A network meta-analysis","volume":"20","author":"Sun","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0710","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/neuonc\/now043","article-title":"Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo","volume":"18","author":"Szabo","year":"2016","journal-title":"Neuro Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0715","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/09168451.2018.1459466","article-title":"Zebularine exerts its antiproliferative activity through S phase delay and cell death in human malignant mesothelioma cells","volume":"82","author":"Takemura","year":"2018","journal-title":"Bioscience Biotechnology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0720","doi-asserted-by":"crossref","unstructured":"Tan, X., Huang, X., Niu, B., Guo, X., Lei, X., & Qu, B. (2022). Targeting GSTP1-dependent ferroptosis in lung cancer radiotherapy: Existing evidence and future directions. Frontiers in Molecular Biosciences, 9,1102158.","DOI":"10.3389\/fmolb.2022.1102158"},{"key":"10.1016\/j.pharmthera.2023.108434_bb9961","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41421-023-00528-0","article-title":"PHF14 enhances DNA methylation of SMAD7 gene to promote TGF-beta-driven lung adenocarcinoma metastasis","volume":"9","author":"Tian","year":"2023","journal-title":"Cell Discovery"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0725","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/jcp.22524","article-title":"Oncosuppressor methylation: a possible key role in colon metastatic progression","volume":"226","author":"Tommasi","year":"2011","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0730","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","article-title":"Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer","volume":"171","author":"Topper","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0735","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0745","doi-asserted-by":"crossref","first-page":"2214499","DOI":"10.1002\/adfm.202214499","article-title":"A microenvironment dual-responsive nano-drug equipped with pd-l1 blocking peptide triggers immunogenic pyroptosis for prostate cancer self-synergistic immunotherapy","volume":"33","author":"Wang","year":"2023","journal-title":"Advanced Functional Materials"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0750","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/21691401.2021.1902337","article-title":"Targeting regulation of the tumour microenvironment induces apoptosis of breast cancer cells by an affinity hemoperfusion adsorbent","volume":"49","author":"Wang","year":"2021","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0755","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/or.2020.7832","article-title":"Methylation of the miR-29b-3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer","volume":"45","author":"Wang","year":"2021","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0760","first-page":"838","article-title":"Engineering SIRP\u03b1 cellular membrane-based nanovesicles for combination immunotherapy","volume":"17","author":"Wang","year":"2023","journal-title":"Nano Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0765","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41419-020-03188-0","article-title":"LncRNA TINCR favors tumorigenesis via STAT3\u2013TINCR\u2013EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0770","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09624","article-title":"Glioblastoma stem-like cells give rise to tumour endothelium","volume":"468","author":"Wang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0775","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1200\/JCO.2022.40.6_suppl.141","article-title":"Effect of PSMA-positive membranes secreted from prostate cancer cells on vascular endothelial cells. In: American Society of Clinical Oncology","volume":"40","author":"Watanabe","year":"2022","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0780","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41388-019-0999-8","article-title":"Metabolic targeting of HIF-1\u03b1 potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer","volume":"39","author":"Wei","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0785","article-title":"miR-29b-3p inhibitor alleviates hypomethylation-related aberrations through a feedback loop between miR-29b-3p and DNA methylation in cardiomyocytes","volume":"10","author":"Wu","year":"2022","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0790","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-022-00873-8","article-title":"Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma","volume":"7","author":"Xi","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0795","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-020-2747-1","article-title":"Structure of nucleosome-bound DNA methyltransferases DNMT3A and DNMT3B","volume":"586","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0800","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvad012","article-title":"PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications","author":"Xu","year":"2023","journal-title":"Cardiovascular Research, cvad012"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0805","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-021-00856-1","article-title":"Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0810","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-023-05743-x","article-title":"Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0815","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1002\/ctm2.450","article-title":"Role of endothelial cells in tumor microenvironment","volume":"11","author":"Yang","year":"2021","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0820","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-022-02568-y","article-title":"Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States","volume":"42","author":"Yang","year":"2023","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0825","first-page":"5056","article-title":"RG108 induces the apoptosis of endometrial cancer Ishikawa cell lines by inhibiting the expression of DNMT3B and demethylation of HMLH1. European Review for Medical and Pharmacological Sciences","volume":"21","author":"Yang","year":"2017"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0830","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41418-018-0271-8","article-title":"TAK1 regulates endothelial cell necroptosis and tumor metastasis","volume":"26","author":"Yang","year":"2019","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0835","doi-asserted-by":"crossref","first-page":"125320","DOI":"10.1016\/j.cej.2020.125320","article-title":"Sustained release of lipophilic gemcitabine from an injectable polymeric hydrogel for synergistically enhancing tumor chemoradiotherapy","volume":"396","author":"Yang","year":"2020","journal-title":"Chemical Engineering Journal"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0840","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/cas.13088","article-title":"Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI","volume":"107","author":"Ye","year":"2016","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0845","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2021.08.038","article-title":"TEC kinase stabilizes PLK4 to promote liver cancer metastasis","volume":"524","author":"Yeung","year":"2022","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0850","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.7150\/thno.44849","article-title":"EZH2-mediated epigenetic silencing of miR-29\/miR-30 targets LOXL4 and contributes to tumorigenesis, metastasis, and immune microenvironment remodeling in breast cancer","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062152","article-title":"Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs","volume":"8","author":"Yoo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0860","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-12-398312-1.00008-1","article-title":"Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure: discovery of a novel DNMT1 inhibitor","volume":"87","author":"Yoo","year":"2012","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0865","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.drudis.2019.08.006","article-title":"DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs","volume":"24","author":"Yu","year":"2019","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0870","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumor microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0875","article-title":"Neutrophil camouflaged stealth nanovehicle for photothermal-induced tumor immunotherapy by triggering pyroptosis","volume":"2207456","author":"Yu","year":"2023","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0880","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bioorg.2019.03.027","article-title":"Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy","volume":"87","author":"Yuan","year":"2019","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0885","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2013.02.033","article-title":"The Arabidopsis nucleosome remodeler DDM1 allows DNA methyltransferases to access H1-containing heterochromatin","volume":"153","author":"Zemach","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0890","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCRESAHA.122.321837","article-title":"NDRG1 signaling is essential for endothelial inflammation and vascular remodeling","volume":"132","author":"Zhang","year":"2023","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0895","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2018.07.015","article-title":"Molecular recognition and in-vitro-targeted inhibition of renal cell carcinoma using a DNA aptamer","volume":"12","author":"Zhang","year":"2018","journal-title":"Molecular Therapy--Nucleic Acids"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0900","doi-asserted-by":"crossref","first-page":"2206169","DOI":"10.1002\/advs.202206169","article-title":"Emerging epigenetic-based nanotechnology for cancer therapy: modulating the tumor microenvironment","volume":"10","author":"Zhang","year":"2023","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0905","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/biom12101487","article-title":"Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0910","doi-asserted-by":"crossref","first-page":"1027726","DOI":"10.3389\/fgene.2022.1027726","article-title":"The role of SELENBP1 and its epigenetic regulation in carcinogenic progression","volume":"13","author":"Zhang","year":"2022","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0915","doi-asserted-by":"crossref","first-page":"1072651","DOI":"10.3389\/fphar.2022.1072651","article-title":"Recent progress in DNA methyltransferase inhibitors as anticancer agents","volume":"13","author":"Zhang","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0920","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature25477","article-title":"Structural basis for DNMT3A-mediated de novo DNA methylation","volume":"554","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0925","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ijc.33863","article-title":"Effect and mechanism of circRNAs in tumor angiogenesis and clinical application","volume":"150","author":"Zhao","year":"2022","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0930","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","article-title":"The DNA methylation landscape of advanced prostate cancer","volume":"52","author":"Zhao","year":"2020","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0935","doi-asserted-by":"crossref","first-page":"e2206518","DOI":"10.1002\/advs.202206518","article-title":"Multiplex digital methylation-specific PCR for noninvasive screening of lung cancer","author":"Zhao","year":"2023","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0940","doi-asserted-by":"crossref","first-page":"2200811","DOI":"10.1002\/adfm.202200811","article-title":"Nanoagonist-mediated GSDME-dependent pyroptosis remodels the inflammatory microenvironment for tumor photoimmunotherapy","volume":"33","author":"Zheng","year":"2022","journal-title":"Advanced Functional Materials"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0945","article-title":"Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: a systematic review and meta-analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0950","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1021\/jacs.1c09574","article-title":"Aptamers entirely built from therapeutic nucleoside analogues for targeted cancer therapy","volume":"144","author":"Zhu","year":"2022","journal-title":"Journal of the American Chemical Society"},{"key":"10.1016\/j.pharmthera.2023.108434_bb0955","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jcb.24959","article-title":"Epigenetic DNA methylation in radiation biology: on the field or on the sidelines?","volume":"116","author":"Zielske","year":"2015","journal-title":"Journal of Cellular Biochemistry"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:34:00Z","timestamp":1759012440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":194,"alternative-id":["S0163725823000980"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108434","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tumor endothelial cells with methyltransferase inhibitors: Mechanisms of action and the potential of combination therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108434"}}